mTOR function in skeletal muscle hypertrophy: Increased ribosomal RNA via cell cycle regulators

American Journal of Physiology - Cell Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Nader, Gustavo A ^a   McLoughlin, Thomas J ^a   Esser, Karyn A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Muscle growth; Ribosome biogenesis

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MAMMALIAN TARGET OF RAPAMYCIN; RETINOBLASTOMA PROTEIN; RIBOSOME RNA; TUMOR SUPPRESSOR PROTEIN; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH REGULATION; MOLECULAR MECHANICS; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RNA ANALYSIS; RNA SYNTHESIS;

ANIMALS; CELL CYCLE; CELL ENLARGEMENT; CELLS, CULTURED; CULTURE MEDIA; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; HYPERTROPHY; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; PHOSPHORYLATION; POL1 TRANSCRIPTION INITIATION COMPLEX PROTEINS; PROTEIN KINASES; RATS; RETINOBLASTOMA PROTEIN; RNA, RIBOSOMAL; SERUM; SIROLIMUS;

ANIMALIA; MAMMALIA;

EID: 27744549321     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00165.2005     Document Type: Article

References (47)

1. Adams GR, Haddad F, and Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 87: 1705-1712, 1999.
2. Bamman MM, Ragan RC, Kim J, Cross JM, Hill VJ, Tuggle SC, and Allman RM. Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J Appl Physiol 97: 1329-1337, 2004.
3. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, and Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019, 2001.
4. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: evidence for involvement of p70 S6 kinase. Circ Res 81: 176-186, 1997.
5. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, and Schreiber SL. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377: 441-446, 1995.
6. Camacho JA, Peterson CJ, White GJ, and Morgan HE. Accelerated ribosome formation and growth in neonatal pig hearts. Am J Physiol Cell Physiol 258: C86-C91, 1990.
7. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583, 1999.
8. Chua BH, Russo LA, Gordon EE, Kleinhans BJ, and Morgan HE. Faster ribosome synthesis induced by elevated aortic pressure in rat heart. Am J Physiol Cell Physiol 252: C323-C327, 1987.
9. Dennis PB, Fumagalli S, and Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 9: 49-54, 1999.
10. Fingar DC and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23: 3151-3171, 2004.
11. Goldspink DF, Cox VM, Smith SK, Eaves LA, Osbaldeston NJ, Lee DM, and Mantle D. Muscle growth in response to mechanical stimuli. Am J Physiol Endocrinol Metab 268: E288-E297, 1995.
12. Hannan KM, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L, Moss T, Poortinga G, McArthur GA, Pearson RB, and Hannan RD. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol 23: 8862-8877, 2003.
13. Hannan RD, Taylor L, Cavanaugh A, Hannan K, and Rothblum LI. UBF and the regulation of ribosomal DNA transcription. In: Transcription of Ribosomal RNA Genes by Eukaryotic RNA Polymerase I. edited by Paule MR. Berlin, Germany: Springer-Verlag. 1998. p. 221-232.
14. Hannan RD, Luyken J, and Rothblum LI. Regulation of rDNA transcription factors during cardiomyocyte hypertrophy induced by adrenergic agents. J Biol Chem 270: 8290-8297, 1995.
15. Hannan RD, Luyken J, and Rothblum LI. Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes. J Biol Chem 271: 3213-3220, 1996.
16. Hannan RD and Rothblum LI. Regulation of ribosomal DNA transcription during neonatal cardiomyocyte hypertrophy. Cardiovasc Res 30: 501-510, 1995.
17. Hornberger TA, McLoughlin TJ, Leszczynski JK, Armstrong DD, Jameson RR, Bowen PE, Hwang ES, Hou H, Moustafa ME, Carlson BA, Hatfield DL, Diamond AM, and Esser KA. Selenoprotein-deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J Nutr 133: 3091-3097, 2003.
18. Ishido M, Kami K, and Masuhara M. In vivo expression patterns of MyoD, p21, and Rh proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol 287: C484-C493, 2004.
19. Ishido M, Kami K, and Masuhara M. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand 180: 281-289, 2004.
20. 12 muscle cells. Exp Cell Res 212: 297-307, 1994.
21. s6k. EMBO J 16: 3693-3704, 1997.
22. Jefferies HB, Reinhard C, Kozma SC, and Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 91: 4441-4445, 1994.
23. Kihm AJ, Hershey JC, Haystead TA, Madsen CS, and Owens GK. Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein. Proc Natl Acad Sci USA 95: 14816-14820, 1998.
24. Kubica N, Bolster DR, Farrell PA, Kimball SR, and Jefferson LS. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2B€ mRNA in a mammalian target of rapamycin-dependent manner. J Biol Chem 280: 7570-7580, 2005.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Mahajan PB. Modulation of transcription of rRNA genes by rapamycin. Int J Immunopharmacol 16: 711-721, 1994.
27. McDermott PJ, Carl LL, Conner KJ, and Allo SN. Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture. J Biol Chem 266: 4409-4416, 1991.
28. McDermott PJ, Rothblum LI, Smith SD, and Morgan HE. Accelerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture. J Biol Chem 264: 18220-18227, 1989.
29. Mita MM, Mita A, and Rowinsky EK. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther 2, Suppl 1: Sl69-S177, 2003.
30. Moss T and Stefanovsky VY. Promotion and regulation of ribosomal transcription in eukaryotes by RNA polymerase I. Prog Nucleic Acid Res Mol Biol 50: 25-66, 1995.
31. 1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J 64: 595-601, 2000.
32. Paule MR. Transcription of Ribosomal RNA Genes by Eukaryotic RNA polymerase I. Berlin, Germany: Springer-Verlag, 1998.
33. 1/S transition. Mol Cell Biol 21: 4246-4255, 2001.
34. Powers T and Walter P. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol Biol Cell 10: 987-1000, 1999.
35. Reiter AK, Anthony TG, Anthony JC, Jefferson LS, and Kimball SR. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver. Int J Biochem Cell Biol 36: 2169-2179, 2004.
36. 3 pathways. Nat Cell Biol 3: 1009-1013, 2001.
37. Schmelzle T and Hall MN. TOR, a central controller of cell growth. Cell 103: 253-262, 2000.
38. Semsarian C, Sutrave P, Richmond DR, and Graham RM. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. Biochem J 339: 443-451, 1999.
39. 1 phase integrators of the mitogenic response. Cold Spring Harb Symp Quant Biol 59: 11-19, 1994.
40. 1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
41. Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, and Izumo S. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107: 1664-1670, 2003.
42. 1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physsiol 275: H2036-H2040, 1998.
43. Torgan CE and Daniels MP. Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro. Mol Biol Cell 12: 1499-1508, 2001.
44. Voit R and Grummt I. Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription. Proc Natl Acad Sci USA 98: 13631-13636, 2001.
45. Voit R, Schäfer K, and Grummt I. Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol Cell Biol 17: 4230-4237, 1997.
46. Yamasaki L. Role of the RB tumor suppressor in cancer. Cancer Treat Res 115: 209-239, 2003.
47. Zhang H, Hannon GJ, and Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994.